137 related articles for article (PubMed ID: 2301374)
41. Unwanted side effect of hydroxyurea.
Najean Y
Ann Hematol; 1996 Feb; 72(2):101. PubMed ID: 8597606
[No Abstract] [Full Text] [Related]
42. New consensus: a unified definition of clinical resistance and/or intolerance to hydroxyurea in essential thrombocythaemia.
Barosi G
Eur J Haematol Suppl; 2007 Oct; (68):24-6. PubMed ID: 17727562
[No Abstract] [Full Text] [Related]
43. Essential thrombocythemia: a retrospective study on the clinical course of 100 patients.
Chistolini A; Mazzucconi MG; Ferrari A; la Verde G; Ferrazza G; Dragoni F; Vitale A; Arcieri R; Mandelli F
Haematologica; 1990; 75(6):537-40. PubMed ID: 2098295
[TBL] [Abstract][Full Text] [Related]
44. Practical approach to treating essential thrombocythaemia: case studies.
Reilly JT
Eur J Haematol Suppl; 2007 Oct; (68):40-2. PubMed ID: 17727566
[No Abstract] [Full Text] [Related]
45. Does hydroxycarbamide therapy really induce leukemic transformation in patients with essential thrombocythemia?
Marcellino B; Hoffman R; Mascarenhas J
Leuk Res; 2019 Jan; 76():94-95. PubMed ID: 30501902
[No Abstract] [Full Text] [Related]
46. Long-term use of hydroxyurea for sickle cell anemia.
Spell DW
JAMA; 2003 Aug; 290(6):752; author reply 754. PubMed ID: 12915422
[No Abstract] [Full Text] [Related]
47. The indolent natural history of essential thrombocythemia: a challenge to new drug development.
Tefferi A
Mayo Clin Proc; 2005 Jan; 80(1):97-8. PubMed ID: 15667035
[No Abstract] [Full Text] [Related]
48. Bone marrow failure due to T-cell large granular lymphocytic leukemia in a patient with essential thrombocythemia.
Selvan SR; Sheehy PF; Heinemann FS; Anbuganapathi S
Leuk Res; 2011 Feb; 35(2):278-82. PubMed ID: 20934219
[No Abstract] [Full Text] [Related]
49. Hydroxyurea-induced fever and hepatitis.
Westerman DA; Schwarer A; Grigg AP
Aust N Z J Med; 1998 Oct; 28(5):657-9. PubMed ID: 9847957
[No Abstract] [Full Text] [Related]
50. [Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemia].
Iizuka H; Yoshimi A; Yamamoto G; Masuda A; Nannya Y; Ichikawa M; Yatomi Y; Kurokawa M
Rinsho Ketsueki; 2013 May; 54(5):468-72. PubMed ID: 23727686
[TBL] [Abstract][Full Text] [Related]
51. Acute myeloid leukemia and myelofibrosis: Simultaneous transformation of essential thrombocythemia during treatment with hydroxyurea.
Nalluru SS; Efe O; Chen Y; Trivedi N
J Cancer Res Ther; 2022; 18(4):1180-1182. PubMed ID: 36149183
[TBL] [Abstract][Full Text] [Related]
52. Hydroxyurea-induced hemolytic anemia in a patient with essential thrombocythemia.
Jabr FI; Shamseddine A; Taher A
Am J Hematol; 2004 Dec; 77(4):374-6. PubMed ID: 15558807
[TBL] [Abstract][Full Text] [Related]
53. Cytogenetic abnormalities and leukemic transformation in hydroxyurea-treated patients with Philadelphia chromosome negative chronic myeloproliferative disease.
Löfvenberg E; Nordenson I; Wahlin A
Cancer Genet Cytogenet; 1990 Oct; 49(1):57-67. PubMed ID: 2397474
[TBL] [Abstract][Full Text] [Related]
54. Acute myeloid leukemia evolving from polycythemia vera in a patient treated with hydroxyurea.
Pulik M; Lionnet F; Genet P; Petitdidier C; Jary L; Touahri T
Am J Hematol; 1996 Nov; 53(3):207-8. PubMed ID: 8895700
[No Abstract] [Full Text] [Related]
55. Transformation of essential thrombocythaemia to T cell acute lymphoblastic leukaemia.
Berkahn LC; Nelson J; Ockelford PA; Browett PJ
Leuk Lymphoma; 1996 Jan; 20(3-4):347-9. PubMed ID: 8624479
[TBL] [Abstract][Full Text] [Related]
56. Towards a rational treatment of essential thrombocythemia, despite limited evidence and old prejudices.
Cazzola M
Haematologica; 2004 Feb; 89(2):137-8. PubMed ID: 15003887
[No Abstract] [Full Text] [Related]
57. Acute pancreatitis as a side effect of anagrelide hydrochloride hydrate: a case report.
Shimazu Y; Fujimura K
Ann Hematol; 2016 Oct; 95(11):1909-10. PubMed ID: 27525727
[No Abstract] [Full Text] [Related]
58. [How should patients with essential thrombocythemia be treated?].
Ikeda Y
Rinsho Ketsueki; 2001 Jun; 42(6):447-51. PubMed ID: 11505520
[No Abstract] [Full Text] [Related]
59. Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia.
Podoltsev NA; Zhu M; Zeidan AM; Wang R; Wang X; Davidoff AJ; Huntington SF; Giri S; Gore SD; Ma X
J Natl Compr Canc Netw; 2019 Mar; 17(3):211-219. PubMed ID: 30865915
[TBL] [Abstract][Full Text] [Related]
60. Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers.
Barbui T; Finazzi G; Dupuy E; Kiladjian JJ; Brière J
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():149-60. PubMed ID: 8951786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
